Results 81 to 90 of about 945,906 (220)
Simplification of Transcatheter Aortic Valve Replacement
Transcatheter aortic valve replacement (TAVR) has led to a paradigm shift in the treatment of patients with symptomatic, severe aortic stenosis. Thus, several randomized clinical trials have demonstrated that TAVR is at least noninferior to surgical aortic valve replacement with regard to ...
Lars Soendergaard, Giulia Costa
openaire +4 more sources
Transcatheter Aortic Valve Durability: Focus on Structural Valve Deterioration
Transcatheter aortic valve replacement has emerged as a valuable alternative to surgical aortic valve replacement in patients with severe aortic stenosis. Given the expansion of transcatheter aortic valve replacement to lower‐risk and younger populations
Antonin Trimaille +11 more
doaj +1 more source
Atrioventricular conduction abnormalities (AVCA) may complicate transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR).
Windecker, Stephan +20 more
core +1 more source
Sleep‐disordered breathing in valvular heart disease: A Modifiable comorbidity
Abstract Sleep‐disordered breathing (SDB) is highly prevalent among patients with valvular heart disease (VHD) and is independently associated with adverse clinical outcomes. The two major phenotypes—obstructive sleep apnea (OSA) and central sleep apnea (CSA)—exhibit distinct distributions across VHD subtypes. CSA predominates in severe aortic stenosis,
Wu Juan +6 more
wiley +1 more source
Transcatheter Aortic Valve Replacement for Aortic Insufficiency
Transcatheter aortic valve replacement (TAVR) has developed into a viable treatment for aortic regurgitation (AR), particularly in high-risk or elderly patients unable to undergo surgery. Early generation devices encountered significant challenges, including high mortality rates, residual paravalvular leaks, and complications such as valve embolisation.
Marwan Amara, Yair Feld
openaire +2 more sources
Background and Purpose Musclin (osteocrin) is a skeletal muscle‐derived peptide that has been implicated in cardioprotective signalling pathways. Its relevance in cancer patients, who frequently experience muscle wasting and cardiotoxicity, remains unclear. This study aimed to determine whether circulating Musclin levels reflect functional capacity and
Jannek Brauer +5 more
wiley +1 more source
Frailty and Five‐Year Mortality After TAVR in Patients Aged 75 Years and Older
In patients aged 75 years and older undergoing transcatheter aortic valve replacement, frailty assessed by the Clinical Frailty Scale was the most robust geriatric factor independently associated with five‐year mortality. This study highlights the specific prognostic value of frailty beyond short‐term outcomes.
Jérémie Huet +4 more
wiley +1 more source
ABSTRACT Introduction Transvenous pacemakers are effective but carry significant short‐ and long‐term complications. Leadless pacemakers were developed to overcome these limitations, however, data in high‐risk patients ineligible for transvenous systems remain limited.
Moshe Katz +7 more
wiley +1 more source
Although the safety of valve-in-valve transcatheter aortic valve replacement has improved, coronary ostium obstruction remains a significant complication, with chimney stenting a possible solution to circumvent this complication. In this case, we discuss
Daniel Nour, MBBS +5 more
doaj +1 more source
A Reassessment of Prophylactic Antibiotics in Low‐Infection‐Risk Electrophysiology Procedures
ABSTRACT Certain electrophysiology (EP) procedures are associated with minimal tissue disruption and do not involve permanent transvenous leads. As a result, these interventions carry a lower risk of device‐ or procedure‐related infection. These procedures include placement of implantable cardiac monitors, leadless pacemakers, and left atrial appendage
Rahel M. Sileshi +14 more
wiley +1 more source

